Current Neuropharmacology
Title:Editorial (Thematic Issue: Translational Perspectives in Treatment-Resistant Mood Disorders)
Volume: 13 Issue: 5
Author(s): Andre F. Carvalho and Roger S. McIntyre
Affiliation:
Export Options
About this article
Cite this article as:
Carvalho F. Andre and McIntyre S. Roger, Editorial (Thematic Issue: Translational Perspectives in Treatment-Resistant Mood Disorders), Current Neuropharmacology 2015; 13 (5) . https://dx.doi.org/10.2174/1570159X1305151013195022
DOI https://dx.doi.org/10.2174/1570159X1305151013195022 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
33
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
The Diagnosis of Drug-Induced Liver Disease
Current Clinical Pharmacology Major CYP450 Polymorphism among Saudi Patients
Drug Metabolism Letters Recent Insights into the Biosynthesis and Biological Activities of Natural Xanthones
Current Medicinal Chemistry A Review of Titanium Di Oxide Nanoparticles - Synthesis, Applications and Toxicity Concerns
Nanoscience & Nanotechnology-Asia ACE2-Ang-(1-7)-Mas Axis in Brain: A Potential Target for Prevention and Treatment of Ischemic Stroke
Current Neuropharmacology Review of Evidence and Perspectives of Flavonoids on Metabolic Syndrome and Neurodegenerative Disease
Protein & Peptide Letters Ethyl Acetohydroxamate Incorporated Chalcones: Unveiling a Novel Class of Chalcones for Multitarget Monoamine Oxidase-B Inhibitors Against Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments?
Current Neuropharmacology Hypothalamic and Neuroendocrine Changes in Huntingtons Disease
Current Drug Targets Alzheimers Disease: From Pathogenesis to Disease-Modifying Approaches
CNS & Neurological Disorders - Drug Targets Designing Multi-Targeted Therapeutics for the Treatment of Alzheimer's Disease
Current Topics in Medicinal Chemistry Synthetic and Biological Vesicular Nano-Carriers Designed for Gene Delivery
Current Pharmaceutical Design Mobile Phone Text Message Interventions in Psychiatry - What are the Possibilities?
Current Psychiatry Reviews Brain Adaptation to Stressful Stimuli: A New Perspective on Potential Therapeutic Approaches Based on BDNF and NMDA Receptors
CNS & Neurological Disorders - Drug Targets Therapeutic Antibodies for Spinal Cord Injury
CNS & Neurological Disorders - Drug Targets Novel Chelators Targeting Cell Cycle Arrest, Acetylcholinesterase, and Monoamine Oxidase for Alzheimer's Therapy
Current Drug Targets Teratogenic Potential of Atypical Antipsychotic Drugs, Quetiapine and Aripiprazole in Rats
Current Psychopharmacology Cannabinoid Receptor Antagonists and the Metabolic Syndrome: Novel Promising Therapeutical Approaches
Mini-Reviews in Medicinal Chemistry Personality and Genetics
Current Psychiatry Reviews mTOR Inhibitors: Facing New Challenges Ahead
Current Medicinal Chemistry